Response by Brubaker et al to Letter Regarding "A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction".

Authors :: Brubaker PH
Nelson WB
Kitzman DW
Source :: Circulation. Heart failure [Circ Heart Fail] 2023 May; Vol. 16 (5), pp. e010419. Date of Electronic Publication: 2023 Apr 18.
Publication Year :: 2023
Abstract: Competing Interests: Disclosures Dr Brubaker has received honoraria as a consultant for Boston Scientific, Boehringer Ingelheim, Corvia Medical, and Merck. Dr Kitzman has received honoraria as a consultant for Bayer, Medtronic, Relypsa, Merck, Corvia Medical, Boehringer Ingelheim, Ketyo, Rivus, NovoNordisk, AstraZeneca‚ and Novartis, grant funding from Novartis, Bayer, NovoNordisk‚ and AstraZeneca‚ and has stock ownership in Gilead Sciences.

Subjects :: Humans
Stroke Volume physiology
Caloric Restriction
Exercise physiology
Exercise Tolerance physiology
Obesity complications
Obesity therapy
Heart Failure therapy
Resistance Training

Full Text Access

Tools